ES361907A1 - Procedure for preparing new benzamidine substitute heterociclic compounds. (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for preparing new benzamidine substitute heterociclic compounds. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES361907A1
ES361907A1 ES361907A ES361907A ES361907A1 ES 361907 A1 ES361907 A1 ES 361907A1 ES 361907 A ES361907 A ES 361907A ES 361907 A ES361907 A ES 361907A ES 361907 A1 ES361907 A1 ES 361907A1
Authority
ES
Spain
Prior art keywords
compounds
salt
substitute
translation
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES361907A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of ES361907A1 publication Critical patent/ES361907A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04F—FINISHING WORK ON BUILDINGS, e.g. STAIRS, FLOORS
    • E04F21/00—Implements for finishing work on buildings
    • E04F21/02—Implements for finishing work on buildings for applying plasticised masses to surfaces, e.g. plastering walls
    • E04F21/04—Patterns or templates; Jointing rulers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Architecture (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Structural Engineering (AREA)
  • Civil Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention comprises compounds of formula wherein A and D are each H, halo or C 1-7 alkyl B is n-butoxy, dialkylaminoalkoxy, alkylsulphonyloxy, arylsulphonyloxy or nitro and R and R1 are each alkyl or together with the intervening nitrogen atom represent an optionally substituted heterocyclic ring which may have N or O as a further heteroatom and pharmaceutically acceptable salts thereof. Preparation of these compounds is from the corresponding nitriles by reaction with NHRR1, the reaction being conducted either with the latter reactant in the form of a Grignard compound or in the presence of a Lewis acid. Subsequently, salt-formation, salt-hydrolysis or salt-interconversion may be effected as required. Pharmaceutical compositions for oral, parenteral, rectal and topical administration comprise the inventive compounds (to which is ascribed anthelmintic activity) and a carrier.
ES361907A 1967-12-28 1968-12-27 Procedure for preparing new benzamidine substitute heterociclic compounds. (Machine-translation by Google Translate, not legally binding) Expired ES361907A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI000764 1967-12-28

Publications (1)

Publication Number Publication Date
ES361907A1 true ES361907A1 (en) 1970-11-01

Family

ID=10994343

Family Applications (1)

Application Number Title Priority Date Filing Date
ES361907A Expired ES361907A1 (en) 1967-12-28 1968-12-27 Procedure for preparing new benzamidine substitute heterociclic compounds. (Machine-translation by Google Translate, not legally binding)

Country Status (10)

Country Link
AT (1) AT286962B (en)
BE (1) BE726123A (en)
CH (1) CH523229A (en)
CS (1) CS155819B1 (en)
DE (1) DE1810836A1 (en)
ES (1) ES361907A1 (en)
FR (1) FR8467M (en)
GB (1) GB1257929A (en)
IL (1) IL31159A (en)
NL (1) NL6818462A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2963600D1 (en) * 1978-04-27 1982-10-28 Laroche Navarron Sa Piperazine methane imine derivatives, methods for their preparation and their therapeutical use

Also Published As

Publication number Publication date
IL31159A (en) 1972-08-30
BE726123A (en) 1969-05-29
FR8467M (en) 1972-01-07
CH523229A (en) 1972-05-31
CS155819B1 (en) 1974-06-24
IL31159A0 (en) 1969-01-29
NL6818462A (en) 1969-07-01
DE1810836A1 (en) 1970-01-08
AT286962B (en) 1971-01-11
GB1257929A (en) 1971-12-22

Similar Documents

Publication Publication Date Title
GB1313689A (en) Quinoxaline derivatives
ES425626A1 (en) Acylxylidide local anaesthetics
ES413639A1 (en) Dopamine derivatives
GB1285016A (en) 3,4-dihydroisoquinoline derivatives
ES390121A1 (en) Carboxamide derivatives and fungicidal compositions containing them
ES395844A1 (en) Tricyclic imines
ES391633A1 (en) 2,2,-diaryl-4-4-aryl-4-hydroxy-piperidino butyramides
ES446126A1 (en) 2-(phenoxyalkylthio)imidazoles and congeners
GB1257929A (en)
GB1084700A (en) Thiosemicarbazones and their production
GB1167711A (en) Diarylcyclopropane Derivatives
US2905590A (en) Thioxanthene derivative
GB1142508A (en) Pyrrole derivatives
ES419142A1 (en) 2-2-2-methyl-5-nitro-1-imidazolyl-ethyl-2-thiopseudoureas and related compounds
ES362888A1 (en) A PROCEDURE FOR PREPARING HYDANTOIN DERIVATIVES.
ES402483A1 (en) Substituted tetrahydroquinolines
ES367158A1 (en) Procedure for the preparation of 3-phenyl-imidazo-tiazol. (Machine-translation by Google Translate, not legally binding)
GB1238416A (en)
ES376507A1 (en) A PROCEDURE FOR PREPARING AN ANTI-DEPRESSION COMPOSITION BASED ON PIPERAZINE AND QUINOLEIN DERIVATIVES.
ES348973A1 (en) Improvements in or relating to New But-2-Yne Derivative and Process for Preparing same
ES350691A1 (en) A procedure for preparing compounds as therapeutic agents comprising derivatives in N-phenyl indoline. (Machine-translation by Google Translate, not legally binding)
ES336293A1 (en) PROCEDURE TO PREPARE BENZOCYCLOHEPTA-THIOPHENE ETHERS.
ES405281A1 (en) Cephalosporin compounds
ES363742A1 (en) N-Substituted 2-Hydroxymorphinanes and Pharmaceutical Compositions containing them
GB1177240A (en) Formamidine Derivatives